U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955715) titled 'Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study' on April 15.
Brief Summary: Pasteurized Donor Human Milk (PDHM) is recognized as providing vital immunological and nutritional benefits to vulnerable infants. Although PDHM is widely used in neonatal intensive care units (NICUs) to prevent infections (necrotizing enterocolitis) and improve infant health outcomes, its use for other populations, such as HIV-exposed infants, has been minimal.
Pasteurized donor human milk is included in the 2023 Canadian Paediatric Society clinical consensus as a potential way to provide HIV-exposed infants some of the immunological ben...